Structure Therapeutics In... (GPCR)
undefined
undefined%
At close: undefined
27.75
0.33%
After-hours Jan 03, 2025, 05:08 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20
Net Income -89.62M -51.32M -38.05K -15.88K
Depreciation & Amortization 295.00K 277.00K 72.00 20.03K
Stock-Based Compensation 8.19M 2.51M 1.49M 570.00K
Other Working Capital 7.83M 815.00K 2.17K -74
Other Non-Cash Items -5.32M -558.00K 241.00 77.00
Deferred Income Tax n/a n/a 27.00 -20.03K
Change in Working Capital 6.97M 2.97M 4.06K 946.00
Operating Cash Flow -79.49M -46.12M -32.16K -14.28K
Capital Expenditures -2.17M -155.00K -1.21K -19
Acquisitions n/a 61.95K -19.07K n/a
Purchase of Investments -416.99M -123.45M -4.21K -21.13K
Sales Maturities Of Investments 151.05M 61.50M 23.28K n/a
Other Investing Acitivies -231.38K -61.95K 19.07K -21.13K
Investing Cash Flow -268.34M -62.11M 17.86K -21.15K
Debt Repayment n/a n/a n/a n/a
Common Stock Repurchased n/a -6.00K n/a n/a
Dividend Paid n/a n/a n/a n/a
Other Financial Acitivies -20.77M 29.02M 103.25K 25.84M
Financial Cash Flow 451.53M 29.01M 103.25K 25.84K
Net Cash Flow 103.70M -79.21M 88.95K -9.59K
Free Cash Flow -81.66M -46.27M -33.37K -14.30K